List of works - Alessandro Conti

Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma.

scientific article

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Biopsy of the anterior prostate gland: technique with end-fire transrectal ultrasound.

scientific article published on December 2010

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

scientific article

CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.

scientific article published on 29 May 2014

Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer

scientific article published on 24 October 2014

Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128.

scientific article

Diagnostic-therapeutic pathway for small lesions of the testis

scientific article published on 30 December 2014

Distal ureter studied with endocavitary end-fire probe: application in adult urology ultrasonographic clinic

scientific article published on December 1, 2010

Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent

scientific article published on 31 May 2011

Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data

scientific article published on 12 October 2018

Emerging concepts on drug resistance in bladder cancer: Implications for future strategies.

scientific article published on 15 May 2015

Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.

scientific article published on 27 January 2014

Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates ⬇️

scientific article published on October 19, 2012

Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside

scientific article published on March 2014

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

scientific article published on 19 September 2014

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.

scientific article

Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.

scientific article published on 28 July 2017

Isolated hydatid cyst of the kidney

scientific article published on 30 December 2012

KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma

scientific article

Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses

scientific article published on January 2015

Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression

scientific article published on 19 February 2014

Metabolic Alterations in Renal and Prostate Cancer.

scientific article published on 15 October 2015

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

scientific article

Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives.

scientific article

New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.

scientific article published on 15 May 2015

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

scientific article published on 05 September 2013

Present and future of personalized medicine in adult genitourinary tumors

scientific article published on January 2015

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

scientific article published on 6 January 2015

Progress of molecular targeted therapies for advanced renal cell carcinoma.

scientific article published on 04 September 2013

Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience.

scientific article published on 30 December 2014

Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors

scientific article published on 08 June 2018

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis

scientific article published on 01 November 2018

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials

scientific article

Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials

scientific article published on 09 June 2015

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

scientific article published on 23 March 2016

Role of STAT3 pathway in genitourinary tumors.

scientific article published on November 2015

Safety and efficacy of percutaneous nephrolithotomy in the Galdakao - Modified Supine Valdivia position: A prospective analysis.

scientific article published on 4 July 2016

Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis.

scientific article published on 12 May 2015

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

scientific article published on 18 July 2014

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

scientific article published on 4 December 2014

Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.

scientific article published on January 2015

Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

scientific article published on 19 December 2019

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

scientific article

The route to personalized medicine in bladder cancer: where do we stand?

scientific article

Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.

scientific article published on 11 April 2015

Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol

scientific article published on 01 December 2012

Treatment of Vesicovaginal Fistulas With Autologous Cell Injections—A Randomized Study in an Animal Model

scientific article published on 12 February 2017

Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.

scientific article published on 07 February 2014

Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma

scientific article

Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients

scientific article published on 22 December 2015

Urinary tract infections in women: etiology and treatment options.

scientific article

[Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience]

scientific article published on 30 December 2012

[The use of haemostatic agents in Urology]

scientific article published on 30 December 2012

α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective randomized study

scientific article published on 20 August 2014

List of works by Alessandro Conti

Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma.

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Biopsy of the anterior prostate gland: technique with end-fire transrectal ultrasound.

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.

Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer

Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128.

Diagnostic-therapeutic pathway for small lesions of the testis

Distal ureter studied with endocavitary end-fire probe: application in adult urology ultrasonographic clinic

Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent

Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data

Emerging concepts on drug resistance in bladder cancer: Implications for future strategies.

Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.

Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates ⬇️

Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.

Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.

Isolated hydatid cyst of the kidney

KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma

Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses

Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression

Metabolic Alterations in Renal and Prostate Cancer.

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives.

New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

Present and future of personalized medicine in adult genitourinary tumors

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

Progress of molecular targeted therapies for advanced renal cell carcinoma.

Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience.

Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials

Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

Role of STAT3 pathway in genitourinary tumors.

Safety and efficacy of percutaneous nephrolithotomy in the Galdakao - Modified Supine Valdivia position: A prospective analysis.

Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis.

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.

Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

The route to personalized medicine in bladder cancer: where do we stand?

Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.

Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol

Treatment of Vesicovaginal Fistulas With Autologous Cell Injections—A Randomized Study in an Animal Model

Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.

Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma

Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients

Urinary tract infections in women: etiology and treatment options.

[Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience]

[The use of haemostatic agents in Urology]

α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective randomized study